Clinical Trials Directory

Trials / Completed

CompletedNCT02523820

Nebulized Corticosteroid for Post Extubation Stridor in Children

Nebulized Corticosteroid for Post Extubation Stridor in Children: A Randomized Double Blind Controlled Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
144 (actual)
Sponsor
Ramathibodi Hospital · Academic / Other
Sex
All
Age
1 Month – 18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the efficacy and adverse effect of nebulized corticosteroid to prevent post-extubation stridor in children.

Detailed description

The guideline for prevention and treatment of post-extubation stridor in children is inconclusive include Nebulized epinephrine and intravenous corticosteroid. Nebulized corticosteroid is alternative treatment for viral croup. the rationale of this study to evaluate the efficacy of nebulized fluticasone propionate to prevent pediatric post-extubation stridor

Conditions

Interventions

TypeNameDescription
DRUGfluticasone propionateFlixotide 1 mg + NSS upto 4 ml nebulized after extubation. Record vital signs and modified Westley score at 0, 15, 30, 60 min and 2,4,6 hours
DRUGPlaceboNSS 4 ml nebulized after extubation. Record vital signs and modified Westley score at 0, 15, 30, 60 min and 2,4,6 hours

Timeline

Start date
2015-01-01
Primary completion
2016-05-30
Completion
2016-08-30
First posted
2015-08-14
Last updated
2017-04-27

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT02523820. Inclusion in this directory is not an endorsement.